Chemours Net Receivables from 2010 to 2025

CC Stock  USD 13.83  0.26  1.92%   
Chemours' Net Receivables is decreasing over the years with slightly volatile fluctuation. Net Receivables is expected to dwindle to about 592.8 M. During the period from 2010 to 2025 Chemours Net Receivables annual values regression line had geometric mean of  723,982,009 and mean square error of 9863.6 T. View All Fundamentals
 
Net Receivables  
First Reported
2013-12-31
Previous Quarter
770 M
Current Value
858 M
Quarterly Volatility
140.4 M
 
Yuan Drop
 
Covid
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours' main balance sheet or income statement drivers, such as Depreciation And Amortization of 315.1 M, Interest Expense of 157.1 M or Selling General Administrative of 786.3 M, as well as many indicators such as Price To Sales Ratio of 0.54, Dividend Yield of 0.0433 or PTB Ratio of 8.14. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
  
Build AI portfolio with Chemours Stock
Check out the analysis of Chemours Correlation against competitors.

Latest Chemours' Net Receivables Growth Pattern

Below is the plot of the Net Receivables of Chemours Co over the last few years. It is Chemours' Net Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
Net Receivables10 Years Trend
Slightly volatile
   Net Receivables   
       Timeline  

Chemours Net Receivables Regression Statistics

Arithmetic Mean731,862,500
Geometric Mean723,982,009
Coefficient Of Variation14.78
Mean Deviation82,171,875
Median742,000,000
Standard Deviation108,186,671
Sample Variance11704.4T
Range408M
R-Value(0.46)
Mean Square Error9863.6T
R-Squared0.21
Significance0.07
Slope(10,498,529)
Total Sum of Squares175565.3T

Chemours Net Receivables History

2025592.8 M
2024770 M
2023610 M
2022626 M
2021720 M
2020511 M
2019674 M

About Chemours Financial Statements

Chemours stakeholders use historical fundamental indicators, such as Chemours' Net Receivables, to determine how well the company is positioned to perform in the future. Although Chemours investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemours' assets and liabilities are reflected in the revenues and expenses on Chemours' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemours Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Receivables770 M592.8 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Chemours Correlation against competitors.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.65)
Dividend Share
1
Earnings Share
0.18
Revenue Per Share
38.66
Quarterly Revenue Growth
0.004
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.